GLU-xx Formulations in Individuals With Impaired Glucose Tolerance

PHASE1TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Impaired Glucose Tolerance
Interventions
DIETARY_SUPPLEMENT

GLU-01

14 day dosing

DIETARY_SUPPLEMENT

GLU-02

14 day dosing

DIETARY_SUPPLEMENT

GLU-03

14 day dosing

DIETARY_SUPPLEMENT

GLU-04

14 day dosing

DIETARY_SUPPLEMENT

GLU-05

14 day dosing

DIETARY_SUPPLEMENT

GLU-06

14 day dosing

Trial Locations (1)

91325

Staywell Research LLC, Northridge

Sponsors
All Listed Sponsors
lead

Afexa Life Sciences Inc

INDUSTRY